Kevin Rakin, Director at Omrix Biopharmaceuticals, Inc. (OMRI), bought 2,000 shares at $13.64 ($27K) on 2008-03-26, disclosed to the SEC on 2008-03-28.
Open-market purchase of $27k OMRI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.64 | 500 | $7K | 25.0% |
| 2 | $13.65 | 1,500 | $20K | 75.0% |
| Total | $13.65 avg | 2,000 | $27K | 100% |
| Filing → |
| ORMP | SELL | 2022-03-22 | $94K | — | Filing → |
| ORMP | SELL | 2021-09-20 | $886K | — | Filing → |
| HSGX | BUY | 2014-12-08 | $124K | — | Filing → |